Mahoney Monica V, Childs-Kean Lindsey M, Khan Parisa, Rivera Christina G, Stevens Ryan W, Ryan Keenan L
Beth Israel Deaconess Medical Center, Boston, MA USA.
Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL USA.
Curr Infect Dis Rep. 2021;23(12):24. doi: 10.1007/s11908-021-00766-x. Epub 2021 Nov 9.
Antimicrobial stewardship within acute care is common and has been expanding to outpatient areas. Some inpatient antimicrobial stewardship tactics apply to outpatient parenteral antimicrobial therapy (OPAT) and complex outpatient antimicrobial therapy (COpAT) management, but differences do exist.
OPAT/COpAT is a growing area of practice and research with its own unique considerations for antimicrobial stewardship. Potential ideas for antimicrobial stewardship in the OPAT/COpAT setting include redesigning the regimen to COpAT instead of OPAT, ensuring the use of the shortest effective duration of antimicrobial therapy; using antimicrobials dosed less frequently, such as long-acting glycopeptides; optimizing antimicrobial susceptibility testing reporting for common OPAT/COpAT drugs; and establishing routine laboratory and safety monitoring. Future consensus is needed to determine validated OPAT program metrics and outcomes.
As more focus is placed on outpatient antimicrobial stewardship, clinicians practicing in OPAT should publish more data regarding OPAT program methods and outcomes as they relate to antimicrobial stewardship. These can involve patient clinical outcomes, OPAT readmission rates, OPAT therapy completion, and central line-related complications.
急性护理中的抗菌药物管理很常见,并且已扩展到门诊领域。一些住院患者抗菌药物管理策略适用于门诊胃肠外抗菌治疗(OPAT)和复杂门诊抗菌治疗(COpAT)管理,但差异确实存在。
OPAT/COpAT是一个不断发展的实践和研究领域,其抗菌药物管理有自身独特的考量因素。在OPAT/COpAT环境中进行抗菌药物管理的潜在思路包括将治疗方案重新设计为COpAT而非OPAT,确保使用最短有效疗程的抗菌治疗;使用给药频率较低的抗菌药物,如长效糖肽类药物;优化常见OPAT/COpAT药物的抗菌药敏试验报告;以及建立常规实验室和安全监测。未来需要达成共识以确定经过验证的OPAT项目指标和结果。
随着越来越多的关注放在门诊抗菌药物管理上,从事OPAT的临床医生应公布更多与抗菌药物管理相关的OPAT项目方法和结果的数据。这些数据可以涉及患者临床结局、OPAT再入院率、OPAT治疗完成情况以及中心静脉导管相关并发症。